U.S. markets close in 1 hour 24 minutes
  • S&P 500

    4,399.75
    +4.49 (+0.10%)
     
  • Dow 30

    34,952.84
    +17.37 (+0.05%)
     
  • Nasdaq

    14,730.50
    +57.82 (+0.39%)
     
  • Russell 2000

    2,232.84
    +6.60 (+0.30%)
     
  • Crude Oil

    71.22
    -2.73 (-3.69%)
     
  • Gold

    1,818.30
    +1.10 (+0.06%)
     
  • Silver

    25.51
    -0.03 (-0.13%)
     
  • EUR/USD

    1.1876
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.1790
    -0.0600 (-4.84%)
     
  • GBP/USD

    1.3894
    -0.0013 (-0.09%)
     
  • USD/JPY

    109.2700
    -0.3450 (-0.31%)
     
  • BTC-USD

    39,776.96
    -1,388.45 (-3.37%)
     
  • CMC Crypto 200

    973.61
    +12.71 (+1.32%)
     
  • FTSE 100

    7,081.72
    +49.42 (+0.70%)
     
  • Nikkei 225

    27,781.02
    +497.43 (+1.82%)
     

Big Prizes: CVS throws in tropical trips, Superbowl tickets in vaccine push

·1 min read

(Reuters) - U.S. pharmacy chain CVS is helping President Joe Biden's push to get 70% of Americans vaccinated against COVID-19 by Independence Day, promising customers prizes ranging from tropical cruises to a trip to Superbowl LVI if they get shots. 

  The move by CVS, which has over 9,600 pharmacies across the United States, adds to the range of incentives being offered by states and companies desperate to get vaccination rates up and American life back to some degree of normality. 

  Ohio Governor Mike DeWine earlier this month offered baseball tickets and beer as well as a $1 million prize draw for those who got at least one vaccine dose. 

  New York's "Vax & Scratch" program is handing out free lottery tickets to adults getting their first dose this week. 

  The CVS scheme will run from June 1 and feature gift cards and prizes from consumer goods giant Procter & Gamble, dating app Hinge and Norwegian Cruise Line in a series of weekly sweepstakes. 

  More than half of all U.S. adults have been fully vaccinated against COVID-19, but the pace of vaccinations has slowed in recent weeks due to ambivalence or skepticism about the medication and declining infections. 

  (Reporting by Manojna Maddipatla in Bengaluru; Editing by Bernard Orr)